Valvasc 5/80 mg, 5/160 mg, 10/160 mg Film-coated tablet
PDF Leaflet Revision Date: 30 August 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderate essential hypertension.
Dosage (summary)
One tablet daily; no adjustment for elderly or mild/moderate renal impairment.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; can cause fetal harm.
Key Drug Interactions
- Lithium
- Potassium-sparing diuretics
- NSAIDs
- CYP3A4 inhibitors
Contraindications
- Hypersensitivity
- Angioedema history
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Dizziness
- Headache
- Hypotension
- Oedema
- Fatigue
Counselling Points
- Take with water
- Monitor blood pressure
- Avoid grapefruit juice
- Report any swelling or allergic reactions
Serious warnings
- Risk of hypotension
- Dual blockade of RAAS contraindicated
- Caution in renal artery stenosis
Important Disclaimer
The Valvasc 5/80 mg, 5/160 mg, 10/160 mg Film-coated tablet professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
